common.study.topics.clinical

Dietary Supplemental Kava

common.study.values.description

“A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics”

Kava is a dietary supplement on the US market and is experiencing a resurgence of its use. Its pharmacokinetic information, however, is lacking which is important for its future effective usage as a dietary supplement or potentially as a botanical therapeutics. This phased trial, based on the recommendation from NIH, is to collect pharmacokinetic data of kava in healthy subjects.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Kava Dietary Supplement

Participants will be given three 75mg kava capsules.

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics

common.study.values.clinical-trial-id

NCT03843502

participant.views.study.view.id

e1w70b